Navigation Links
SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years
Date:12/8/2011

MOUNTAIN VIEW, Calif., Dec. 8, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that results from the SEQUEL study were published in The American Journal of Clinical Nutrition, a peer-reviewed journal with broad, multidisciplinary readership. The SEQUEL study evaluated the long-term efficacy and safety of Qnexa in 676 overweight and obese subjects with cardiometabolic disease. In addition to 10% sustained weight loss, the study also found that significantly more placebo patients became diabetic over the two years as compared to patients treated with Qnexa. The data suggest that Qnexa, in conjunction with lifestyle modification, may provide a well-tolerated and effective option for the sustained treatment of obesity and the potential to prevent many in this population from progressing to type 2 diabetes.

"Recent data show that diabetes, like obesity, has become a rapidly growing epidemic, with nearly 1 in 10 adults potentially affected by the disease," said lead investigator W. Timothy Garvey M.D., director of the Nutrition Obesity Research Center, University of Alabama at Birmingham. "Results from the SEQUEL study underscore Qnexa's potential as a non-surgical option for sustained weight loss and improvements in comorbidities in overweight and obese patients."

Specific results as published in AJCN are as follows:

  • Patients treated with Qnexa had significant, sustained weight loss compared to those in the placebo group over two years. 
  • Average weight loss at week 108 was -9.3% and -10.5%, respectively, for the mid- and top-dose as compared to -1.8% for the placebo group (least-squares mean ITT-LOCF).
  • Qnexa patients had improved cardiovascular and metabolic risk factors and a decrease in the need for associated medications in comparison with the placebo group.
  • Placebo patients had a three times greater li
    '/>"/>

  • SOURCE VIVUS, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Additional Analysis from Two-Year Sequel Study of QNEXA Featured at The 2011 Annual Scientific Meeting of The Obesity Society
    2. Data From QNEXA Sequel Study Featured at the 47th EASD Annual Meeting
    3. SequelMed EMR Version 8 Certified by Ohio Board of Pharmacy
    4. Sequel Systems, Inc. Meaningful Use EHR Receives ONC-ATCB 2011/2012 Certification
    5. Sequella and University of Maryland Restate Exclusive License for Jointly Owned Event Marker System Technology
    6. Sequella Receives American Recovery and Reinvestment Funding Through the NIH
    7. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
    8. Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
    9. TIs new MSP430™ microcontrollers enable more performance and higher precision in home automation, industrial and portable medical applications
    10. GiiResearch.com: Computed Tomography (CT) Systems - Technological Advances and Positive Clinical Trial Evidences to Drive the Market
    11. GiiResearch.com: Insulin Pumps - Availability of Reimbursement and Favorable Clinical Trial Data to Drive Market Growth
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/22/2014)... , Dec, 22, 2014  Eiger BioPharmaceuticals Incorporated ... study of lonafarnib in patients with chronic hepatitis ... at the National Institutes of Health (NIH) Clinical ...  The double-blinded, randomized, placebo-controlled, dose ascending study evaluated ... and 200 mg twice daily for 28 days.  ...
    (Date:12/22/2014)... NEW YORK , Dec. 22, 2014 /PRNewswire/ ... developing novel therapies for the treatment of chronic ... subjects has been dosed in a pharmacokinetic and ... receptor antagonist for neuropathic pain. Racemic ... treatment of various pain states and substitution therapy ...
    (Date:12/19/2014)... Friday, December 19 edition of USA ... features Konica Minolta, the company announced today. The supplement will focus ... organizations. In addition to the print section that ... New York , Chicago , ... Minneapolis and San Francisco , a ...
    Breaking Medicine Technology:Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 3USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2
    ... Echo Therapeutics, Inc. (Nasdaq: ECTE ), ... as a non-invasive, wireless, transdermal continuous glucose monitoring ... transdermal drug delivery, today announced that the company ... States Patent and Trademark Office for its SYMPHONY ...
    ... JOSE, Calif., Sept. 14, 2011 Teikoku Pharma USA, ... agreement with Verde Environmental Technologies Inc. ("Verde"), a company ...  Verde is a privately held company, founded by former ... Verde obtained rights to develop products, which are ...
    Cached Medicine Technology:Echo Therapeutics Receives Registered Trademarks for Symphony® and Prelude® 2Echo Therapeutics Receives Registered Trademarks for Symphony® and Prelude® 3Licensing Agreement for Pharmaceutical Disposal Technology Between Teikoku Pharma USA, Inc. and Verde Environmental Technologies Inc. 2
    (Date:12/22/2014)... DC (PRWEB) December 22, 2014 ... its year-long, professional development programs this month. Faculty ... which focuses on nurse educators fast-tracked for administrative ... the Leadership Development Program for Simulation Educators, featuring ... specialized area of nursing education. , Twenty ...
    (Date:12/22/2014)... 22, 2014 Parker & Sons, Inc. ... in Arizona home contracting services reports a record number ... quality services in 2014. As a company that has ... 1970s, Parker and Sons is a business that is ... works side-by-side with other top quality companies in Arizona ...
    (Date:12/21/2014)... (PRWEB) December 22, 2014 Recently, BambooFlooringChina.com, ... durable strand woven bamboo flooring collection , and launched ... 25%. The promotion is valid until Jan. 30, 2015. ... woven bamboo is the hardest bamboo flooring available today; ... resembling that of traditional teak hardwoods. Strand woven bamboo ...
    (Date:12/21/2014)... BellasDress.com offers a wide range of women’s dresses, ... its BellasDress Christmas Sale , offering big discounts ... BellasDress is a famous online supplier of women’s dresses; ... series of promotions. The dress experts of the company ... are proud of offering high quality wedding dresses and ...
    (Date:12/21/2014)... 21, 2014 When families in Coral Gables ... they call? The new answer is Lice Troopers . ... 33134, their newest treatment center will be the new go-to ... and without the use of harmful chemicals or pesticides. ... January 1, 2015. Like the company’s first clinic (located at ...
    Breaking Medicine News(10 mins):Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 3Health News:BambooFlooringChina.com Announced Its Durable Strand Woven Bamboo Flooring Collection 2Health News:BellasDress.com Announces its BellasDress Christmas Sale 2Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2
    ... , Working Together to Share Records Safely, Improve ... of Veterans Affairs (VA) and Kaiser Permanente today announced an ... Nation,s heroes. VA and Kaiser Permanente are launching a pilot ... Nationwide Health Information Network (NHIN) created by the Department of ...
    ... ... of Feeding America,s SNAP Outreach Efforts , CHICAGO, Nov. 25 ... $1 million donation from the Bank of America Charitable Foundation to ... Nutrition Assistance Program (SNAP), formerly named the Food Stamp Program. ...
    ... to normal human development - the Wnt/Wingless (Wnt) and ... ways that can promote tumor cell invasion and metastasis, ... Cancer Center report in the Nov. 25 issue of ... involves three signaling components known to correlate with invasive ...
    ... Melvin R. Kaplan, MD, FACP, a former Board Chair ... became Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center ... Physicians for his lifetime devotion to the care of patients. ... American College of Physicians will present Dr. Kaplan with the ...
    ... 2009 Physicians at UT Southwestern Medical Center soon will ... patients with upper spinal-cord injuries or other diseases that keep ... St. Paul is only one of only two sites ... equipped to implant the device, called the NeuRx Diaphragm Pacing ...
    ... mitochondrial function plays in insulin production , WEDNESDAY, ... people with type 2 diabetes to lose insulin-producing ... treatments, U.S. researchers say. , Mitochondria provide energy ... when insulin-producing beta cells in the pancreas can,t ...
    Cached Medicine News:Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 3Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:1 of LA BioMed's founders to be honored 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2
    Stainless steel threaded Steinman Pins available in point types A,D, E, and F....
    Round Bevel-Point Pin Sets available in 2.3mm, 3.1mm, 4.7mm, and 6.3mm sizes....
    Knowles Pins are available in 9" (228mm) overall length with 9/64" (3.5mm) shaft diameter and 1/4" (6.4mm) square bead....
    ... Unite Device is the anterior alternative to the ... device features the same 70% fenestrations as Ray ... is paramount in the formation of new bone. ... system promotes load sharing between the device and ...
    Medicine Products: